- Services
- Therapeutic Areas
- Model Systems
- In Vitro
- In Vivo
- Technologies
- Service Type
- About Us
- Our Science
- Start Your Study Now
Middle lobe of liver: adenocarcinoma, cholangiocarcinoma on basis of IHC results, grade II-III. IHC results: Hepa(-), CK7(++), CK19(++), CD34(abundant blood sinus), CPC3(-), KI67(30%+), CD56(part +), CD117(-), HSP70(+), GS(scattered +), LCK(++).
| Summary | |
|---|---|
| Cancer Type | cholangiocarcinoma |
| Subtype | ICC |
| Grade | NA |
| Stage | NA |
| Ethnicity | Asian |
| Gender | NA |
| Age | NA |
| Pathology Diagnosis | Middle lobe of liver: adenocarcinoma, cholangiocarcinoma on basis of IHC results, grade II-III. IHC results: Hepa(-), CK7(++), CK19(++), CD34(abundant blood sinus), CPC3(-), KI67(30%+), CD56(part +), CD117(-), HSP70(+), GS(scattered +), LCK(++). |
| Biopsy Site | Liver, middle lobe |
| Treatment History | NA |
| Pathology QC | Moderately differentiated adenocarcinoma (P7) |
| Special Features | PIK3CA E545K |
| Mouse Strain | Balb/c nu |
| TMA | NA |
| Viral Status in PDX | NA |
| Available In | CB_CN |
| RNA Seq | P4 |
| Exome Seq | P4 |
